Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Impact of obesity on vascular calcification in patients with chronic kidney disease.
Clin Nephrol. 2022 Jan;97(1):10-17. doi: 10.5414/CN110523.
Clin Nephrol. 2022.
PMID: 34402786
Significant associations between bone mineral density and vascular calcification in patients with different stages of chronic kidney disease.
Uhlinova J, Kuudeberg A, Metsküla K, Lember M, Rosenberg M.
Uhlinova J, et al.
BMC Nephrol. 2022 Oct 5;23(1):327. doi: 10.1186/s12882-022-02955-9.
BMC Nephrol. 2022.
PMID: 36199013
Free PMC article.
Item in Clipboard
Adverse lifestyle and health-related quality of life: gender differences in patients with and without chronic conditions.
Põlluste K, Aart A, Kallikorm R, Kull M, Kärberg K, Müller R, Ots-Rosenberg M, Tolk A, Uhlinova J, Lember M.
Põlluste K, et al. Among authors: uhlinova j.
Scand J Public Health. 2016 Mar;44(2):209-16. doi: 10.1177/1403494815615763. Epub 2015 Nov 9.
Scand J Public Health. 2016.
PMID: 26553249
Item in Clipboard
Abdominal Aortic Calcifications Predict Survival in Peritoneal Dialysis Patients.
Mäkelä S, Asola M, Hadimeri H, Heaf J, Heiro M, Kauppila L, Ljungman S, Ots-Rosenberg M, Povlsen JV, Rogland B, Roessel P, Uhlinova J, Vainiotalo M, Svensson MK, Huhtala H, Saha H.
Mäkelä S, et al. Among authors: uhlinova j.
Perit Dial Int. 2018 Sep-Oct;38(5):366-373. doi: 10.3747/pdi.2017.00043. Epub 2018 Jan 31.
Perit Dial Int. 2018.
PMID: 29386304
Item in Clipboard
Peritoneal Dialysis Penetration and Peritonitis Rate at a Single Centre during Last Decade.
Uhlinova J, Pechter U, Kermes K, Ots-Rosenberg M.
Uhlinova J, et al.
Int J Nephrol. 2011;2011:470426. doi: 10.4061/2011/470426. Epub 2011 Jun 15.
Int J Nephrol. 2011.
PMID: 21747997
Free PMC article.
Item in Clipboard
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators.
Rovin BH, et al.
Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3.
Lancet. 2023.
PMID: 37931634
Clinical Trial.
Item in Clipboard
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial.
Heerspink HJL, Radhakrishnan J, Alpers CE, Barratt J, Bieler S, Diva U, Inrig J, Komers R, Mercer A, Noronha IL, Rheault MN, Rote W, Rovin B, Trachtman H, Trimarchi H, Wong MG, Perkovic V; PROTECT Investigators.
Heerspink HJL, et al.
Lancet. 2023 May 13;401(10388):1584-1594. doi: 10.1016/S0140-6736(23)00569-X. Epub 2023 Apr 1.
Lancet. 2023.
PMID: 37015244
Clinical Trial.
Item in Clipboard
Cite
Cite